Pfizer, playing catch-up with Novartis, bags FDA approval for drug combo in lung cancer
Fierce Pharma
OCTOBER 12, 2023
Pfizer is expanding the reach of its BRAF-MEK combo as the pharma giant looks to further build up its oncology presence. Pfizer is expanding the reach of its BRAF-MEK combo as the pharma giant looks to further build up its oncology presence.
247 
Let's personalize your content